Stock listing
OTC:BLPH Bellerophon Therapeutics Inc Stock
Follow Bellerophon Therapeutics Inc into a list and get an email when it puts out news.
Delisted OTC:BLPH no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- OTC:BLPH
- Asset type
- Stock
- Exchange
- OTC
- Currency
- USD
Bellerophon Therapeutics Inc on 6ix
- Decks
- 9 decks · latest Jun 5, 2023
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (June 2023) | Technical | 9 slides | Jun 5, 2023 |
| Investor Presentation (January 2022) | Investor deck | 25 slides | Jan 5, 2022 |
| Investor Presentation (January 2021) | Investor deck | 32 slides | Jan 11, 2021 |
| Corporate Update (March 2020) | Corporate update | 16 slides | Mar 31, 2020 |
| Technical Presentation (December 2019) | Technical | 10 slides | Dec 17, 2019 |
| Investor Presentation (January 2019) | Investor deck | 29 slides | Jan 7, 2019 |
| Investor Presentation (October 2018) | Investor deck | 30 slides | Oct 16, 2018 |
| Investor Presentation (September 2018) | Investor deck | 30 slides | Sep 5, 2018 |
| Technical Presentation (September 2015) | Technical | 18 slides | Sep 25, 2015 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robert Nelsen Other companies: City Therapeutics, Inc. (Board Director · Since at least Oct 19, 2026); Kardigan, Inc. (Director · Since at least Jun 22, 2026); Metsera, Inc. (Director · Since at least Nov 13, 2025); Prime Medicine, Inc. (Board Member · Since at least Oct 19, 2022); Sana Biotechnology, Inc. (Director · Since at least Feb 3, 2021); Lyell Immunopharma, Inc. (Director · Jun 16, 2021 – Jun 14, 2024 · Past); Revolution Healthcare Acquisition Corp (Director · Mar 17, 2021 – Mar 17, 2021 · Past); Beam Therapeutics Inc. (Director · Feb 5, 2020 – Mar 31, 2021 · Past); Vir Biotechnology, Inc. (Director · Oct 10, 2019 – May 30, 2024 · Past); Karuna Therapeutics Inc (Director · Jun 27, 2019 – Apr 13, 2021 · Past); Unity Biotechnology Inc (Director · May 2, 2018 – Jun 18, 2020 · Past); Denali Therapeutics Inc. (Director · Dec 7, 2017 – Jun 2, 2021 · Past); Syros Pharmaceuticals, Inc. (Director · Jun 29, 2016 – Jun 8, 2017 · Past); Juno Therapeutics Inc (Director · Dec 18, 2014 – Mar 5, 2018 · Past); Sage Therapeutics Inc (Director · Jul 17, 2014 – Nov 9, 2015 · Past); Fate Therapeutics, Inc. (Director · Sep 30, 2013 – Oct 4, 2013 · Past); Agios Pharmaceuticals, Inc. (Director · Jul 23, 2013 – Mar 3, 2017 · Past); Kythera Biopharmaceuticals Inc (Director · Oct 10, 2012 – Aug 14, 2014 · Past); NeurogesX Inc (Director · May 1, 2007 – Jun 7, 2012 · Past); Adolor Corp (Director · May 18, 2006 – May 17, 2007 · Past) | Director · Feb 12, 2015 – Feb 13, 2015 · Past |
| Scott Huennekens Other companies: NeuroPace, Inc. (Director · Since at least Jan 6, 2025); QuidelOrtho Corporation (Director · Since at least Dec 6, 2024); Envista Holdings Corporation (Director · Since at least Sep 20, 2019); Hyperfine, Inc. (Director · Dec 22, 2021 – Jun 12, 2024 · Past); Acutus Medical Inc. (Director · Aug 5, 2020 – Jun 15, 2023 · Past); NuVasive Inc (Director · Oct 1, 2018 – Sep 1, 2023 · Past); EndoChoice Holdings Inc (Director · Jun 5, 2015 – Nov 22, 2016 · Past); Volcano Corp (President & Chief Executive Of, Director · Jun 14, 2006 – Feb 17, 2015 · Past) | Director · May 12, 2015 – May 12, 2015 · Past |
| Daniel Tassé Other companies: DBV Technologies SA (Chief Executive Officer · Since at least Jan 1, 2021); Regenxbio Inc. (Independent Board Member · Since at least Aug 15, 2016); Mallinckrodt Inc (Interim Pres-Hospital Business · May 1, 2015 – May 1, 2015 · Past) | Director · Feb 13, 2015 – Jun 21, 2018 · Past |
| Jonathan M Peacock Other companies: Avantor, Inc. (Director · May 16, 2019 – May 8, 2025 · Past); Kite Pharma Inc (Director · Jun 19, 2014 – Oct 3, 2017 · Past); Amgen Inc. (EVP & CFO · Apr 25, 2013 – Oct 28, 2013 · Past) | Director · Feb 13, 2015 – Mar 31, 2021 · Past |
| Mary Ann Cloyd Other companies: Fresh del Monte Produce, Inc. (Director · Since at least May 1, 2019); Angel Pond Holdings Corp (Director · May 6, 2021 – May 6, 2021 · Past); ChronoScale Corporation (Director · Dec 29, 2020 – May 16, 2025 · Past) | Director · Feb 11, 2016 – Jun 7, 2023 · Past |
| Matthew S Holt Other companies: R1 RCM Inc (Director · Jun 22, 2022 – Nov 19, 2024 · Past); Signify Health Inc (Director · Feb 10, 2021 – Mar 29, 2023 · Past); Avantor, Inc. (Director · May 16, 2019 – May 12, 2022 · Past) | Director · Feb 12, 2015 – Jun 17, 2016 · Past |
| Theodore T Wang Other companies: MariaDB plc (Director · Dec 16, 2022 – Jun 29, 2023 · Past); Angel Pond Holdings Corp (Chief Executive Officer, Director · May 6, 2021 – Dec 16, 2022 · Past); ChronoScale Corporation (Director · Sep 11, 2017 – Nov 10, 2020 · Past) | Director · Nov 27, 2017 – Jun 7, 2023 · Past |
| Scott P Bruder Other companies: Stryker Corporation (VP, Chief Med&Scientific Off. · Feb 12, 2013 – Feb 12, 2014 · Past); Becton, Dickinson and Company (SrVP; Chief Technology Officer · Sep 1, 2007 – Nov 23, 2010 · Past) | Director · May 12, 2015 – Jun 7, 2023 · Past |
| Adam Weinstein Other companies: New Mountain Finance Corporation (NMFC Executive Vice President · Since at least May 19, 2011) | Director · Feb 12, 2015 – Sep 22, 2017 · Past |
| Andre V Moura Other companies: Avantor, Inc. (Director · May 16, 2019 – May 16, 2019 · Past) | Director · Apr 28, 2016 – Sep 10, 2020 · Past |
All 28 people
| Person | Seat |
|---|---|
| Naseem Amin Other companies: Avadel Pharmaceuticals PLC (Director · Since at least May 17, 2024) | Director · Jun 29, 2015 – Jun 7, 2023 · Past |
| Amit Agrawal | Chief Operating Officer · Jul 8, 2015 – Jul 8, 2015 · Past |
| Amy Edmonds | VP Clinical Operations & Admin · May 22, 2019 – Sep 26, 2019 · Past |
| Assaf Korner | CFO · Jan 8, 2018 – Nov 15, 2019 · Past |
| Bobae Kim | VP Reg. Affairs & Quality · Mar 30, 2023 – Jun 7, 2023 · Past |
| Crispin Teufel | Director · Mar 18, 2019 – Jun 7, 2023 · Past |
| Deborah Quinn | Chief Medical Officer · Oct 21, 2015 – Jun 12, 2018 · Past |
| Fabian Tenenbaum | Chief Executive Officer, Director · Feb 29, 2016 – Nov 15, 2019 · Past |
| Jens Luehring | Director · Feb 13, 2015 – Jun 21, 2018 · Past |
| Manesh Naidu | Chief Business Officer · Feb 13, 2015 – Mar 12, 2015 · Past |
| Martin Dekker | See Remarks · Jan 19, 2016 – Jun 7, 2023 · Past |
| Matthew Bennett | Director · Mar 22, 2018 – Sep 10, 2020 · Past |
| Megan Schoeps | Principal Financial Officer · Mar 10, 2017 – Dec 13, 2017 · Past |
| Nicholas Laccona | FINANCIAL OFFICER, (PFO & PAO) · Sep 30, 2021 – Feb 10, 2023 · Past |
| Parag Suresh Shah | VP of Business Operations · Apr 6, 2016 – Jun 7, 2023 · Past |
| Peter Fernandes | See Remarks · May 18, 2015 – Jun 7, 2023 · Past |
| Reinilde Heyrman | Chief Clinical Dev. Officer · Feb 13, 2015 – Mar 12, 2015 · Past |
| Wassim FARES | Chief Medical Officer · Sep 10, 2020 – Sep 10, 2020 · Past |
Log in to ask 6ix AI your own questions about Bellerophon Therapeutics Inc.